Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5W25
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,343
Award facts
- Contract value 100% obligated
- $9,342.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $9,342.91 delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of January 7, 2026. The product will be performed and delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle supplying a wide range of medications and medical supplies to military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems. The company maintains significant contract vehicles with the Defense Logistics Agency and other federal agencies, demonstrating capability to meet government procurement requirements through open competition. Zepbound is a GLP-1 receptor agonist medication used for weight management, representing the type of specialized pharmaceutical commodity the company routinely supplies through its federal contract portfolio across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F5W25?
SPE2DR26F5W25 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F5W25 worth?
The government has obligated $9,343 on SPE2DR26F5W25.
Is contract SPE2DR26F5W25 an order under another contract?
Yes. SPE2DR26F5W25 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F5W25 competed?
The extent of competition for SPE2DR26F5W25 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award